Journal article
The prevalence of food allergy and other allergic diseases in early childhood in a population-based study: HealthNuts age 4-year follow-up
- Abstract:
-
Background
The HealthNuts study previously reported interim prevalence data showing the highest prevalence of challenge-confirmed food allergy in infants internationally. However population-derived prevalence data on challenge-confirmed food allergy and other allergic diseases in preschool-aged children remains sparse. This study aims to report the updated prevalence of food allergy at age 1 year from the whole cohort, and to report the prevalence of food allergy, asthma, eczema and allergic rhinitis, at age 4 years.
Methods
HealthNuts is a population-based cohort study with baseline recruitment of 5276 1 year-old children who underwent SPT to 4 food allergens and those with detectable SPT had formal food challenges. At age 4 years, parents completed a questionnaire (81.3% completed) and those who previously attended the HealthNuts clinic at age 1 or reported symptoms of a new food allergy were invited for an assessment which included SPT and oral food challenges. Data on asthma, eczema and allergic rhinitis were captured by validated ISAAC study questionnaires.
Results
The prevalence of challenge-confirmed food allergy at age 1 and 4 years was 11.0% and 3.8%, respectively. At age 4 years peanut allergy prevalence was 1.9% for peanut (95% CI 1.6-2.3%), egg allergy 1.2% (95% CI 0.9-1.6%), and sesame allergy 0.4% (95% CI 0.2-0.6%). Late-onset peanut allergy at age 4 years was rare (0.2%). The prevalence of current diagnosed asthma was 10.8% (95% CI 9.7-12.1%), current eczema 16.0 % (95% CI 14.7-17.4%) and current allergic rhinitis 8.3% (95% CI 7.2-9.4%). 40-50% of this population-based cohort experienced symptoms of an allergic disease in the first 4 years of their life.
Conclusions
Although the prevalence of food allergy decreased between ages 1 and age 4 years in this population based cohort, the prevalence of any allergic disease amongst 4 year old children in Melbourne, Australia, is remarkably high.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 347.0KB, Terms of use)
-
- Publisher copy:
- 10.1016/j.jaci.2017.02.019
Authors
- Publisher:
- Elsevier
- Journal:
- Journal of Allergy and Clinical Immunology More from this journal
- Volume:
- 140
- Issue:
- 1
- Pages:
- 145-153.e8
- Publication date:
- 2017-05-14
- Acceptance date:
- 2017-02-03
- DOI:
- EISSN:
-
1097-6825
- ISSN:
-
0091-6749
- Pmid:
-
28514997
- Language:
-
English
- Keywords:
-
- Pubs id:
-
pubs:697004
- UUID:
-
uuid:816a4b21-be00-481f-8b6a-297468a7727d
- Local pid:
-
pubs:697004
- Source identifiers:
-
697004
- Deposit date:
-
2018-04-18
Terms of use
- Copyright holder:
- American Academy of Allergy, Asthma and Immunology
- Copyright date:
- 2017
- Notes:
- © 2017 American Academy of Allergy, Asthma and Immunology. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: http://dx.doi.org/10.1016/j.jaci.2017.02.019
If you are the owner of this record, you can report an update to it here: Report update to this record